NasdaqCM - Delayed Quote • USD
Avalo Therapeutics, Inc. (AVTX)
At close: May 14 at 4:00 PM EDT
After hours: May 14 at 7:48 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -1.18 | -0.19 | -0.91 | -0.97 |
| Low Estimate | -1.18 | -0.19 | -0.91 | -0.97 |
| High Estimate | -1.18 | -0.19 | -0.91 | -0.97 |
| Year Ago EPS | -204 | -141.6 | -114 | -0.91 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | 475k | 643k | 1.92M | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -232.8 | -192 | -264 | -4.8 |
| EPS Actual | -204 | -141.6 | -26.4 | -116.21 |
| Difference | 28.8 | 50.4 | 237.6 | -111.41 |
| Surprise % | 12.40% | 26.20% | 90.00% | -2,321.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -1.18 | -0.19 | -0.91 | -0.97 |
| 7 Days Ago | -1.18 | -0.19 | -0.91 | -0.97 |
| 30 Days Ago | -4.8 | -4.8 | -16.8 | -16.8 |
| 60 Days Ago | -4.8 | -4.8 | -16.8 | -16.8 |
| 90 Days Ago | -4.8 | -4.8 | -16.8 | -16.8 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | AVTX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 99.40% | -- | -- | 7.30% |
| Next Qtr. | 99.90% | -- | -- | 10.90% |
| Current Year | 99.20% | -- | -- | 4.60% |
| Next Year | -6.60% | -- | -- | 13.00% |
| Next 5 Years (per annum) | -- | -- | -- | 10.89% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Upgrade | Oppenheimer: Perform to Outperform | 4/16/2024 |
Related Tickers
BDRX Biodexa Pharmaceuticals Plc
1.1000
+13.99%
TPST Tempest Therapeutics, Inc.
3.4000
+3.66%
ALLR Allarity Therapeutics, Inc.
0.7885
-0.94%
PXMD PaxMedica, Inc.
0.2070
-9.53%
TCBP TC Biopharm (Holdings) Plc
1.1500
+1.77%
ENVB Enveric Biosciences, Inc.
0.8205
-3.41%
ADIL Adial Pharmaceuticals, Inc.
1.4400
-0.35%
IBIO iBio, Inc.
1.8800
+3.56%
ATXI Avenue Therapeutics, Inc.
3.8400
-2.78%
CYCC Cyclacel Pharmaceuticals, Inc.
2.8400
+11.81%